a Trial of Using SMS Reminder Among Diabetic Retinopathy Patients in Rural China
NCT ID: NCT01837121
Last Updated: 2018-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
237 participants
INTERVENTIONAL
2015-01-31
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Laser Treatment for Diabetic Eye Disease in China : A Pilot Randomized Trial
NCT02956759
Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens
NCT02587741
A Trial on Ophthalmologist-delivered Health Education on Top of Routine Community Care
NCT04490941
0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients
NCT02595606
Navigation Laser Versus Traditional Laser Photocoagulation for Mild Diabetic Macular Edema
NCT03641144
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
the SMS group
the diabetic retinopathy patient in the SMS group will receive a SMS reminder message about the revisit time,address 1 week and 3 day before the appointment.
the SMS reminder message
the SMS reminder message will sent to the SMS group patients 1 week and 3 day before there appointment,to remind them the exact time and address of the revisit appointment.
the control group
the diabetic retinopathy patient in the control group won't get any reminder message before the appointment.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
the SMS reminder message
the SMS reminder message will sent to the SMS group patients 1 week and 3 day before there appointment,to remind them the exact time and address of the revisit appointment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. The first re-visit appointment time is outside our study period.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Orbis
OTHER
The World Diabetes Foundation
OTHER
Sun Yat-sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Congdon Nathan
vice director,Blindness Prevention and Treatment Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nathan G Congdon, MD,MPH
Role: STUDY_DIRECTOR
Blindness Prevention and Treament Department,Zhongshan Ophthalmic Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Blindness Preventment and Treatment Department, Zhongshan Ophthalmic Center
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZOC-WDF-SMS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.